Combined interferon-alpha and inosiplex treatment of subacute sclerosing panencephalitis: a case report
- PMID: 12962429
- PMCID: PMC11917909
- DOI: 10.1016/S1607-551X(09)70485-1
Combined interferon-alpha and inosiplex treatment of subacute sclerosing panencephalitis: a case report
Abstract
Subacute sclerosing panencephalitis (SSPE) is rare in Taiwan. On admission to hospital, a 15-year-old boy was diagnosed with SSPE based on the clinical picture, electroencephalogram, cerebrospinal fluid studies, and brain biopsy. The initial clinical picture was a decline in school performance and a change in personality, followed by progressive tic-like involuntary movements and mental impairment for 8 months, then a rapidly progressive course. After the patient was treated with oral inosiplex and intraventricular interferon-alpha (IFN-alpha), his condition stabilized and the neurologic disability index score improved slightly. There were no major side effects during treatment except for a transient initial elevation of body temperature that lasted for several days. Oral inosiplex and intraventricular IFN-alpha appear to be safe and effective. Early identification and aggressive treatment of SSPE is important.
Similar articles
-
Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis.Neurology. 1992 Mar;42(3 Pt 1):488-91. doi: 10.1212/wnl.42.3.488. Neurology. 1992. PMID: 1372397
-
Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study.J Child Neurol. 2003 Dec;18(12):819-27. doi: 10.1177/088307380301801201. J Child Neurol. 2003. PMID: 14736075 Clinical Trial.
-
Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon.Neurology. 1997 Feb;48(2):526-8. doi: 10.1212/wnl.48.2.526. Neurology. 1997. PMID: 9040751
-
[Therapy and prognosis in subacute sclerosing panencephalitis].Nihon Rinsho. 2007 Aug;65(8):1483-6. Nihon Rinsho. 2007. PMID: 17695288 Review. Japanese.
-
Treatment of subacute sclerosing panencephalitis: an overview.Drug Intell Clin Pharm. 1984 May;18(5):375-81. doi: 10.1177/106002808401800503. Drug Intell Clin Pharm. 1984. PMID: 6202474 Review.
Cited by
-
Movement Disorders in Patients with Subacute Sclerosing Panencephalitis: A Systematic Review.Mov Disord Clin Pract. 2024 Jul;11(7):770-785. doi: 10.1002/mdc3.14062. Epub 2024 May 15. Mov Disord Clin Pract. 2024. PMID: 38748762 Free PMC article.
References
-
- Asher DM. Slow viral infections of the human nervous system. In Scheld WM, Whitley DJ, Durack DT, eds. Infections of the Central Nervous System. New York: Raven Press. 1991, 141–156.
-
- Oga T, Ikeda A, Nagamine T, et al. Implication of sensorimotor integration in the generation of periodic dystonic myoclonus in subacute sclerosing panencephalitis (SSPE). Mov Disord. 2000; 15: 1173–1183. - PubMed
-
- Foley JM. The nervous system. In Robbins SL, ed. The Pathologic Basis of Disease. Philadelphia: WB Saunders. 1974, 1323–1550.
-
- Britt WJ. Slow virus disease. In Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. 2nd ed. Philadelphia: WB Saunders. 1987, 1851–1854.
-
- Anlar B, Yalaz K, Oktem F, Kose G. Long‐term follow‐up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha‐interferon. Neurology. 1997; 48: 526–528. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources